Lexpos News

The Department of Health and Social Care (DHSC) has today (25/04/2023) granted the following list of price concessions for April 2023: Drug Pack size Price concession Buprenorphine 8mg sublingual tablets sugar free 7 £4.41 Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment 30 £9.23 Carbocisteine 375mg capsules 120 £7.24 Chloramphenicol 1% eye ointment 4 £5.20 Chlorpromazine [...]

The post April 2023 Price Concessions 3rd Update appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxybutynin 5mg modified-release tablets. MSN/2023/048 Tier 2 – medium impact Date of issue 24th April 2023 Oxybutynin 5mg modified-release tablets are out of stock until w/c 1st May 2023. Oxybutynin immediate release formulations (tablets and liquid) remain available and can support [...]

The post Medicine Supply Notification: Oxybutynin 5mg modified-release tablets appeared first on PSNC Website.

As part of the ongoing #SaveOurPharmacies campaign, further copies of the window poster are being distributed to community pharmacies in England. Following distribution of the poster in the March issue of Pharmacy Magazine, additional copies are also going out through other Communication International Group (CIG) titles. The copies will be available in the April issues [...]

The post Watch out for additional copy of #SaveOurPharmacies poster appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has today (21/04/2023) granted the following list of price concessions for April 2023: Drug Pack size Price concession Bicalutamide 150mg tablets 28 £3.99 Bisacodyl 5mg gastro-resistant tablets 60 £4.99 Bisoprolol 2.5mg tablets 28 £1.02 Cinacalcet 30mg tablets 28 £11.95 Clarithromycin 250mg/5ml oral suspension 70 £5.50 Clotrimazole 1% [...]

The post April Price Concessions 2nd Update appeared first on PSNC Website.

Class 4 Medicines Defect Information: Co-amoxiclav 125/31.25mg/5ml, 250/62.5mg/5ml powder for oral suspension (Sandoz Limited) Drug alert number: EL (23)A/14 Date issued: 20 April 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name: Co-amoxiclav 125/31.25mg/5ml powder for oral suspension, PL 04416/0514 (Sandoz Limited) SNOMED [...]

The post MHRA Class 4 Medicines Defect Information: Co-amoxiclav 125/31.25mg/5ml, 250/62.5mg/5ml powder for oral suspension (Sandoz Limited) appeared first on PSNC Website.